Story
Binance Acquires $100 Million Stake in Stablecoin Issuer Circle
Summary
Cryptocurrency exchange Binance has purchased a $100 million stake in Circle, the issuer of the USDC stablecoin, as part of an expanded five-year commercial partnership to promote the dollar-pegged token.
Binance has acquired a $100 million stake in Circle, the company behind the major dollar-pegged stablecoin USDC, deepening the strategic ties between the two digital asset firms. The investment is part of a broader commercial agreement aimed at promoting the use of USDC on Binance's global platform.
Deal Details
In a regulatory filing on Tuesday, Circle disclosed the details of the transaction, which took place on September 17. The stablecoin issuer sold approximately 1.24 million shares to Binance at a purchase price of $80.84 per share, totaling the $100 million investment.
Following the announcement, shares of Circle (CRCL) were last seen trading up nearly 2% in premarket activity. The stock has gained roughly 19% year-to-date, bringing its market capitalization to approximately $24 billion.
Expanded Partnership
AdThe investment underpins an expanded commercial arrangement with a five-year term. Under the agreement, Binance has committed to undertaking specific activities to promote USDC on its exchange. In return, Circle stated it has agreed to pay Binance a "monthly incentive fee."
Either party can terminate the arrangement early under certain specified conditions, according to the filing. This partnership solidifies the relationship between the world's largest crypto exchange and the issuer of one of the market's most prominent stablecoins.
Context for Investors
USDC is a stablecoin designed to maintain a 1-to-1 peg with the U.S. dollar. It plays a critical role in the cryptocurrency ecosystem, facilitating rapid fund transfers and providing a stable store of value for traders. According to data from CoinMarketCap, USDC has a market capitalization of nearly $75 billion.
Read next
More on Stocks
AI Infrastructure Firm Accelevation Sets IPO Terms, Targeting Up to $5.4 Billion Valuation
AI infrastructure provider Accelevation is targeting a valuation of up to $5.37 billion and aims to raise as much as $720 million in its upcoming U.S. initial public offering, capitalizing on strong investor interest in artificial intelligence.
Quest, Labcorp Shares Tumble on Proposed Medicare Reimbursement Cuts
Shares of Quest Diagnostics and Labcorp fell sharply in premarket trading after the Centers for Medicare & Medicaid Services proposed significant cuts to laboratory testing fees, set to begin in 2027.
Roche's Obesity Drug Enicepatide Shows 15.5% Weight Loss in Mid-Stage Diabetes Trial
Swiss drugmaker Roche announced its experimental obesity drug, enicepatide, helped patients with type 2 diabetes achieve an average 15.5% weight loss and significant blood sugar control in a mid-stage study.
DoorDash to Pay $131.5 Million in NYC Settlement Over Worker Pay Issues
Food delivery giant DoorDash has agreed to a $131.5 million settlement with New York City following a probe that found the company underpaid or delayed payments to its delivery workers.